Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE242030 |
CRISPR-Cas screen in ILC2 identifies Mef2d as a regulator of GATA3 and type-2 immunity [ChIP-Seq]
|
17 | Ana Ferreira | Jul 03, 2024 | ||||
GSE262028 |
CRISPR-Cas screen in ILC2 identifies Mef2d as a regulator of GATA3 and type-2 immunity [CRISPR screen]
|
8 | Ana Ferreira | Jul 03, 2024 | ||||
GSE210338 |
Genome-wide CRISPR KO screen in BMDMs [Bulk CIRSPR Screen]
|
9 | Sandra Melo | Jul 01, 2024 | ||||
GSE235693 |
Leukemic initiation in Jam-C-deficient HSPC reveals AP-1/TNF- gene expression signature as a biomarker for AML
|
12 | Michel Aurrand-Lions | Jul 01, 2024 | ||||
GSE262410 |
Model integration of circadian and sleep-wake driven contributions to rhythmic gene expression reveals novel regulatory principles
|
124 | Maxime Jan | Jul 01, 2024 | ||||
GSE266664 |
Fasting induces a metabolic switch and a spatial redistribution of tanycyte functions on lipid processing and neuronal interactions.
|
3 | Federico Santoni | Jul 01, 2024 | ||||
GSE270515 |
p53R172H and p53R245W Mutants Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator
|
18 | Xiaoping Su | Jul 01, 2024 | ||||
GSE212026 |
Chromatin accessibility in B16 and 4T1 cell lines with decitabine treatment [ATAC-seq]
|
12 | Eric Greer | Jun 30, 2024 | ||||
GSE212027 |
Transcriptome analysis in B16F10 and 4T1 cell lines with decitabine treatment [RNA-seq]
|
12 | Eric Greer | Jun 30, 2024 | ||||
GSE212029 |
B16 and 4T1 cell lines with decitabine treatment
|
36 | Eric Greer | Jun 30, 2024 | ||||
GSE218362 |
Paternal exposure alone induces alcohol-related birth defects in a mouse model: Implications of paternal drinking in FAS birth defects.
|
16 | Michael Golding | Jun 30, 2024 | ||||
GSE236110 |
Adipose cDC1s contribute to obesity-associated white adipose tissue inflammation and metabolic dysfunction through STING-dependent IL-12 production
|
5 | Joey Han Tang Li | Jun 30, 2024 | ||||
GSE242150 |
Lymphatic-derived 25-hydroxycholesterol promotes immunity in melanoma by inhibiting PPAR-γ in tumor associated macrophages and monocytes
|
6 | Natacha Civic | Jun 30, 2024 | ||||
GSE261285 |
small RNA-sequencing analysis of db/db mice exudate from subcutaneously implanted sponges
|
20 | Nikolaos Kalavros | Jun 30, 2024 | ||||
GSE190603 |
Bulk RNA sequence and bulk ATAC sequence of treated murine CD8+ T cells
|
25 | Bin Zhang | Jun 28, 2024 | ||||
GSE242029 |
CRISPR screens and ILC2-targeted Boolean circuitry reveal Mef2d-potentiation of type-2 immunity [RNA-Seq]
|
7 | Ana Ferreira | Jun 28, 2024 | ||||
GSE242147 |
CRISPR-Cas screen in ILC2 identifies Mef2d as a regulator of GATA3 and type-2 immunity
|
36 | Ana Ferreira | Jun 28, 2024 | ||||
GSE262743 |
Comprehensive single cell transcriptomics analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathways
|
10 | Alexander Ferrena | Jun 28, 2024 | ||||
GSE264317 |
Changes in tryptophan de novo NAD synthesis associated with chronic intestinal inflammation
|
20 | Rhian Stavely | Jun 28, 2024 | ||||
GSE269812 |
Augmenting fibronectin levels in injured adult CNS promotes axon regeneration in vivo [scRNA-seq]
|
2 | Ephraim F Trakhtenberg | Jun 28, 2024 |